美国国防部长Pete Hegseth在7月宣布了一项针对现役陆军成员的强制性睾酮检测计划1。根据发表在《美国医学会杂志》上的研究，这一筛查方案可能导致多达25%的现役陆军成员被检测出低睾酮结果1，而实际患病率远低于这一比例1。
医学专业组织对该计划提出了严重顾虑。美国内分泌学会和美国泌尿外科协会均建议反对普遍筛查1。专业人士指出，过度筛查可能导致不必要的医学评估、不准确诊断、过度治疗和生育问题等潜在伤害1。五角大楼已于9月发布了临床指导，并继续推进该计划的执行1。
U.S. Defense Secretary Pete Hegseth announced a mandatory testosterone screening program for active duty Army personnel in July, a policy that has drawn significant medical scrutiny.1 According to research published in the Journal of the American Medical Association, the screening initiative could result in as many as 25 percent of active duty Army members receiving low testosterone test results, far exceeding the actual prevalence of the condition.1
Medical professional organizations have raised concerns about the broad screening approach. The American Endocrine Society and the American Urological Association have recommended against widespread testosterone screening, citing risks of unnecessary medical evaluations, inaccurate diagnoses, excessive treatment, and potential harm including infertility.1 The Pentagon released clinical guidance for the program in September and has moved forward with implementation.1
评论
还没有评论，欢迎留下第一条。